StemCell Institute Inc. (7096.T)
Tokyo · JPY · Healthcare · Biotechnology
¥716 (+0.70%) as of
Key statistics
- Market cap
- 7.21B
- P/E (TTM)
- 48.64
- Forward P/E
- 9.41
- EPS (TTM)
- 14.72
- Dividend yield
- 0.00%
- 52-week range
- 627.00 – 976.00
- Beta
- 0.64
- Revenue (TTM)
- 2.81B
- Profit margin
- 5.51%
- Volume
- 1.10k
About StemCell Institute Inc.
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is involved in Cell management and transportation services; extraction, purification, processing, storage, testing, and sale of components derived from biological tissues; research, and development, and dissemination of cell-based therapies. Its also offers the manufacturing, wholesale distribution, and sale of pharmaceuticals and medical devices. In addition, the company operates and manages medical facilities, conducts real estate leasing and property management activities, and provides information processing, information, and advertising services, as well as business control and management functions to support its overall operations and affiliated business activities. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tokyo, Japan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.